Advancements in Precision Medicine for Myelodysplastic Neoplasms and Acute Myeloid Leukemia: A Review on Genomics to Targeted Therapies

Key Points

• Precision medicine transforms treatment strategies for myelodysplastic neoplasms and acute myeloid leukemia, enhancing patient outcomes.
• Key advancements in genomics drive the development of targeted therapies for these conditions, improving effectiveness.
• Observational analysis of existing literature highlights the need for integrating genetic profiling in treatment plans.
• Improvements in treatment based on genomic data suggest a shift towards personalized medicine, increasing response rates.

Abstract